Researchers have identified an abnormal metabolic pathway which drives cancer cell growth in particular glioblastoma brain cancer subtypes.
Researchers discover an enzyme, IDH, which facilitates the breakdown of specific amino acids makes glioblastoma brain cancer particularly aggressive.
An experimental nanotechnology drug crosses the blood-brain barrier and targets brain tumor cells, a new study suggests. The drug also blocks the growth of tumor blood vessels.
Researchers discover a way to adjust the malignancy of glioma brain cancer cells in a newly developed 3D hydrogel. The new material mimics the conditions in the brain.
Researchers suggest neural stem cells could be resistant to radiation. The stem cells could be roused from a hibernation-like state in order to reproduce and generate new cells which have the ability to migrate, replace injured cells and restore lost function.
The RIP1 protein can either protect or destroy brain tumors, a new study suggests.
A new study reports a novel combination of two targeted drugs dramatically slowed the growth of brain cancer tumors and significantly extended survival in mouse models.
Researchers confirm an association between a common MRI contrasting agent and abnormalities on brain MRI.